Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 3.95%
March 31, 2026 4.16%
December 31, 2025 -24.13%
September 30, 2025 -2.99%
June 30, 2025 0.89%
March 31, 2025 5.62%
December 31, 2024 -0.78%
September 30, 2024 35.34%
June 30, 2024 -4.22%
March 31, 2024 2.66%
December 31, 2023 -13.62%
September 30, 2023 -102.6%
June 30, 2023 -9.18%
March 31, 2023 8.19%
December 31, 2022 -5.47%
September 30, 2022 -6.34%
June 30, 2022 -0.85%
Date Value
March 31, 2022 4.16%
December 31, 2021 -9.34%
September 30, 2021 -9.20%
June 30, 2021 -16.42%
March 31, 2021 -4.91%
December 31, 2020 -28.32%
September 30, 2020 -15.18%
June 30, 2020 -9.07%
March 31, 2020 -7.47%
December 31, 2019 -1.21%
September 30, 2019 1.30%
June 30, 2019 4.59%
March 31, 2019 4.31%
December 31, 2018 2.05%
September 30, 2018 7.91%
June 30, 2018 -8.15%
March 31, 2018 9.88%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Zoetis, Inc. 28.00%
Eli Lilly & Co. 30.88%
ANI Pharmaceuticals, Inc. 8.65%
EyePoint, Inc. -18.63K%
Amylyx Pharmaceuticals, Inc. --